← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2013Last known activity
Mar 18, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06942520Lead sponsorPhase 2Mar 18, 2025
- NCT06172257Overall official - principal investigatorPhase 3Dec 31, 2023
- NCT05903794Overall official - principal investigatorPhase 1Jul 24, 2023
- NCT02363621Lead sponsorPhase 2Jan 1, 2015
- NCT01926977Lead sponsorPhase 1/Phase 2Sep 1, 2013
Details
- Last known activity
- Mar 18, 2025